J&J submits FDA application for myasthenia gravis drug nipocalimab Source: Seekingalpha
Browsing: FDA
FDA approves Illumina’s TruSight Oncology biomarker test Source: Seekingalpha
FDA accepts SpringWorks’ application for mirdametinib for NF1-PN Source: Seekingalpha
Liquidia requests preliminary injunction against FDA for Tyvaso 3-year exclusivity Source: Seekingalpha
Roth starts CG Oncology at purchase, cites anticipated FDA filing Source: Seekingalpha
Soleno lead asset granted FDA priority review Source: Seekingalpha
FDA approves Illumina’s TruSight Oncology biomarker test Source: Seekingalpha
(*5*) FDA clears (*2*) Omnipod 5 for type 2 diabetes Source: Seekingalpha
Soleno lead asset granted FDA priority review Source: Seekingalpha
To guarantee this doesn’t occur sooner or later, please allow Javascript and cookies in your browser.Is this occurring to you often? Please report it on our…